Novo Nordisk
NVO
#32
Rank
S$373.77 B
Marketcap
$84.63
Share price
-6.27%
Change (1 day)
-50.56%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Cash on Hand

Cash on Hand as of December 2024 : S$4.93 Billion

According to Novo Nordisk's latest financial reports the company has S$4.93 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Novo Nordisk - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$4.98 B-15.62%
2023-12-31S$5.91 B29.92%
2022-12-31S$4.55 B26.46%
2021-12-31S$3.59 B29%
2020-12-31S$2.78 B-10.82%
2019-12-31S$3.12 B-4.43%
2018-12-31S$3.27 B-19.48%
2017-12-31S$4.06 B-4.17%
2016-12-31S$4.24 B-0.01%
2015-12-31S$4.24 B23.59%
2014-12-31S$3.43 B1.13%
2013-12-31S$3.39 B-2.81%
2012-12-31S$3.49 B-11.56%
2011-12-31S$3.94 B7.01%
2010-12-31S$3.68 B6.38%
2009-12-31S$3.46 B26.82%
2008-12-31S$2.73 B31.52%
2007-12-31S$2.07 B49.9%
2006-12-31S$1.38 B4.87%
2005-12-31S$1.32 B11.65%
2004-12-31S$1.18 B33.09%
2003-12-31S$0.89 B103.24%
2002-12-31S$0.43 B-46.48%
2001-12-31S$0.81 B155.37%
2000-12-31S$0.32 B4.4%
1999-12-31S$0.30 B61.08%
1998-12-31S$0.19 B-30.57%
1997-12-31S$0.27 B48.04%
1996-12-31S$0.18 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$27.55 B 457.83%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.60 B-6.75%๐Ÿ‡บ๐Ÿ‡ธ USA
S$14.61 B 195.82%๐Ÿ‡บ๐Ÿ‡ธ USA
S$11.10 B 124.72%๐Ÿ‡ซ๐Ÿ‡ท France